Notice of Award of a Single-Source Cooperative Agreement To Fund Institut Pasteur de Cote d'Ivoire (IPCI), 12964-12965 [2022-04790]

Download as PDF 12964 Federal Register / Vol. 87, No. 45 / Tuesday, March 8, 2022 / Notices Orphans and Vulnerable Children (PNOEV) was created. In December of that same year, it was officially decreed as an acting body of the MFFE; making the MFFE the only government institution that can do the following: (1) Reinforce collaboration between community-based organizations (CBOs) and health facilities; (2) Work closely with the Institute National de Formation Social (INFS) to improve financial, administrative, and management modules; (3) Work with the Ministry of National Education (MEN) to address gender-based violence (GBV) against adolescents and children; and (4) Maintain interventions in the social sector for control of the HIV epidemic clearly making this the sole and uniquely strong organization that can move this role forward, attain sustainability, and transfer back this role to the government. Summary of the Award Recipient: Ministry of Women, Families and Children (MFFE). Purpose of the Award: The purpose of this award is to continue to build a sustainable national response to address the needs of OVC and their families and others highly affected by HIV/AIDS. This NOFO will support services to mitigate these effects in order to improve health and well-being outcomes of adults and children. In addition, the MFFE will work closely with the MEN to address adolescent girls’ vulnerability by providing schoolbased HIV and prevention gender and education interventions. Amount of Award: The approximate year 1 funding amount will be $3,000,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the availability of funds. Funding award amounts for years 2–5 will be set at continuation. Authority: This program is authorized under Public Law 108–25 (the United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act of 2003). Period of Performance: September 30, 2022 through September 29, 2027. lotter on DSK11XQN23PROD with NOTICES1 Dated: March 2, 2022. Terrance Perry, Chief Grants Management Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–04817 Filed 3–7–22; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 17:25 Mar 07, 2022 Jkt 256001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Award of a Single-Source Cooperative Agreement To Fund Servicos Provinciais de Sau´de de Zambezia (SPS Zambezia), Mozambique Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $2,000,000 for Year 1 of funding to the Servicos Provinciais de Sau´de de Zambezia (SPS Zambezia), Mozambique. The award will strengthen the institutional capacity of SPS Zambezia to plan, coordinate, and supervise HIV-related activities to contribute to accelerated progress towards the 95–95–95 goals (95% of HIV-positive individuals knowing their status, 95% of those receiving ART [Antiretroviral therapy], and 95% of those achieving viral suppression) and ensure sustainable control of the epidemic in Mozambique. Funding amounts for years 2–5 will be set at continuation. DATES: The period for this award will be September 30, 2022 through September 29, 2027. FOR FURTHER INFORMATION CONTACT: Meghan Duffy, Center for Global Health, Centers for Disease Control and Prevention, U.S. Embassy Maputo, Avenida Marginal nr 5467, Sommerschield, Distrito Municipal de KaMpfumo Caixa Postal 783 CEP 0101– 11 Maputo, Moc ¸ambique, Telephone: 800–232–6348, Email: wwp2@cdc.gov. SUPPLEMENTARY INFORMATION: The single-source award will focus on building institutional capacity of the SPS in Zambezia for program development and planning and strengthening program implementation and oversight of activities related to HIV prevention, care, support, and treatment services funded by PEPFAR in Mozambique. SPS Zambezia is in a unique position to conduct this work, as it leads all health services within the province of Zambezia. In Mozambique, the governmental public health infrastructure is organized into the central or national entity of the Mozambique Ministry of Health/ Ministe´rio da Sau´de (MOH/MISAU), the SUMMARY: PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 Provincial Health Directorates (DPSs) that implement activities at the primary healthcare level, and the Provincial Health Service (SPS) that lead all health services within the province of Zambezia. The SPSs in Mozambique are government organizations established by law and mandated to plan, coordinate, and supervise all healthrelated activities at the tertiary and secondary level, including HIV/AIDS activities, within their provincial jurisdiction. Summary of the Award Recipient: SPS Zambezia, Mozambique. Purpose of the Award: The purpose of this award is to strengthen the institutional capacity of SPS Zambezia to plan, coordinate, and supervise HIVrelated activities to contribute to accelerated progress towards the 95–95– 95 goals and ensure sustainable control of the epidemic in Mozambique. Amount of Award: The approximate year 1 funding amount will be $2,000,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the availability of funds. Funding amounts for years 2–5 will be set at continuation. Authority: This program is authorized under Public Law 108–25 (the United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act of 2003). Period of Performance: September 30, 2022 through September 29, 2027. Dated: March 2, 2022. Terrance Perry, Chief Grants Management Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–04783 Filed 3–7–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Award of a Single-Source Cooperative Agreement To Fund Institut Pasteur de Cote d’Ivoire (IPCI) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $1,000,000, for Year 1 of funding to the IPCI to sustain decentralization of HIV-associated microbiology at regional hospitals and to expand interventions to additional SUMMARY: E:\FR\FM\08MRN1.SGM 08MRN1 Federal Register / Vol. 87, No. 45 / Tuesday, March 8, 2022 / Notices regional hospitals. The award will improve support to and the coordination of the TB and OIs laboratory network for quality assured diagnosis of TB/DR–TB, including smear microscopy (LED), Lipoarabinomannan Assay (LF–LAM) for the diagnosis and screening of active tuberculosis in people with HIV, solid and liquid culture, and molecular WHOrecommended diagnostic tests (LIPA, Xpert Ultra). Funding amounts for years 2–5 will be set at continuation. DATES: The period for this award will be September 30, 2022 through September 29, 2027. FOR FURTHER INFORMATION CONTACT: Titania Techeira, Center for Global Health, Centers for Disease Control and Prevention, CDC Coˆte d’Ivoire, U.S. Embassy B.P. 730 Abidjan Cidex 03, Telephone: 800–232–6348, Email: iux2@ cdc.gov. SUPPLEMENTARY INFORMATION: The single-source award will strengthen IPCI as the National Reference Laboratory for TB and microbiology tests. This will enable IPCI to better and further sustain the efforts in 27 Anti-Tuberculosis Centers (CATs) and in 16 regional reference laboratories previously supported for decentralized microbiology diagnosis. IPCI is in a unique position to conduct this work as it is the designated laboratory institution in charge of integrated Disease Surveillance and Response (IDSR) in Cote d’Ivoire by the Ministry of Health (MOH) and Ministry of Scientific Research. IPCI is responsible for the implementation, monitoring, and evaluation of population-based TB, malaria and epidemic disease surveillance, including HIV opportunistic infections, as well as prevention and care policies and interventions. lotter on DSK11XQN23PROD with NOTICES1 Summary of the Award Recipient: IPCI. Purpose of the Award: The purpose of this award is to sustain decentralization of HIV-associated microbiology at regional hospitals and to expand interventions to additional regional hospitals. It will improve support to and the coordination of the TB and OIs laboratory network for quality assured diagnosis of TB/DR–TB, including smear microscopy (LED), Lipoarabinomannan Assay (LF–LAM) for the diagnosis and screening of active tuberculosis in people with HIV, solid and liquid culture, and molecular WHOrecommended diagnostic tests (LIPA, Xpert Ultra). Amount of Award: The approximate year 1 funding amount will be VerDate Sep<11>2014 17:25 Mar 07, 2022 Jkt 256001 $1,000,000 in Federal Fiscal Year (FYY) 2022 funds, subject to the availability of funds. Funding amounts for years 2–5 will be set at continuation. Authority: Public Law 108–25 (the United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act of 2003). Period of Performance: September 30, 2022 through September 29, 2027. Dated: March 2, 2022. Terrance Perry, Chief Grants Management Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–04790 Filed 3–7–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Award of a Single-Source Cooperative Agreement To Fund Machakos County Government, Makueni County Government, Kitui County Government, and Nairobi County Government (Represented by Nairobi Metropolitan Services), Kenya Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS) announces the award of approximately $1,400,000 for Year 1 of, and an average 1 year award amount of $350,000, funding to the Machakos County Government, Makueni County Government, Kitui County Government, and Nairobi County Government (represented by Nairobi Metropolitan Services). The awards will advance current efforts to attain ownership, leadership, and implementation capacity for HIV services by the Nairobi, Machakos, Makueni and Kitui County governments, and to achieve and sustain HIV epidemic control through sustainable high-quality comprehensive HIV prevention and treatment services. Funding amounts for years 2–5 will be set at continuation. DATES: The period for this award will be September 30, 2022 through September 29, 2027. FOR FURTHER INFORMATION CONTACT: Dr. Lucy Nganga, Center for Global Health, Centers for Disease Control and Prevention, KEMRI Campus, Mbagathi Road—off Mbagathi Way, P.O. Box 606, Village Market, 00621, Nairobi, Kenya. SUMMARY: PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 12965 Telephone: 800–232–6348, Email: hon5@cdc.gov. SUPPLEMENTARY INFORMATION: The single-source awards will support Nairobi, Machakos, Makueni and Kitui County Governments to achieve two goals: (1) Implementation and expansion of comprehensive HIV services with the goal of achieving and maintaining epidemic control, and (2) Strengthening the capacity of Nairobi, Machakos, Makueni and Kitui county governments’ Department of Health Services to progressively manage, sustain and transition to ownership of HIV service delivery. The 2010 Kenyan constitution (Chapter 11, article 174–176;189) https://www.klrc.go.ke/index.php/ constitution-of-kenya; the Fourth Schedule, Part 2 https://www.klrc.go.ke/ index.php/constitution-of-kenya/167schedules-schedules/fourth-scheduledistribution-of-functions-betweennational-and-the-county-governments and the Kenya Health Act (Act No. 21 2017) https://kenyalaw.org:8181/exist/ kenyalex/actview.xql?actid= No.%2021%20of%202017 prescribed roles for the new county government, whereby each county is responsible for provision of health care services to its residents. Nairobi, Machakos, Makueni and Kitui County Governments’ Departments of Health Services have the sole mandate to manage and implement Nairobi, Machakos, Makueni and Kitui Counties’ public health response to HIV and implementing partners must work through these entities. CDC’s support to Nairobi, Machakos, Makueni and Kitui County will directly increase the capacity of Department of Health Services to support long-term sustainable HIV service delivery response in Kenya. Summary of the Award Recipient: Machakos County Government, Makueni County Government, Kitui County Government, and Nairobi County Government (represented by Nairobi Metropolitan Services). Purpose of the Award: The purpose of this award is to advance current efforts to attain ownership, leadership, and implementation capacity for HIV services by the Nairobi, Machakos, Makueni and Kitui County governments, and to achieve and sustain HIV epidemic control through sustainable high-quality comprehensive HIV prevention and treatment services. This will be achieved through health system strengthening and increased coverage of high quality, client-centered comprehensive HIV prevention and treatment services, resulting in a E:\FR\FM\08MRN1.SGM 08MRN1

Agencies

[Federal Register Volume 87, Number 45 (Tuesday, March 8, 2022)]
[Notices]
[Pages 12964-12965]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04790]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Single-Source Cooperative Agreement To Fund 
Institut Pasteur de Cote d'Ivoire (IPCI)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $1,000,000, for Year 1 of funding to the IPCI to 
sustain decentralization of HIV-associated microbiology at regional 
hospitals and to expand interventions to additional

[[Page 12965]]

regional hospitals. The award will improve support to and the 
coordination of the TB and OIs laboratory network for quality assured 
diagnosis of TB/DR-TB, including smear microscopy (LED), 
Lipoarabinomannan Assay (LF-LAM) for the diagnosis and screening of 
active tuberculosis in people with HIV, solid and liquid culture, and 
molecular WHO-recommended diagnostic tests (LIPA, Xpert Ultra). Funding 
amounts for years 2-5 will be set at continuation.

DATES: The period for this award will be September 30, 2022 through 
September 29, 2027.

FOR FURTHER INFORMATION CONTACT: Titania Techeira, Center for Global 
Health, Centers for Disease Control and Prevention, CDC C[ocirc]te 
d'Ivoire, U.S. Embassy B.P. 730 Abidjan Cidex 03, Telephone: 800-232-
6348, Email: [email protected].

SUPPLEMENTARY INFORMATION: The single-source award will strengthen IPCI 
as the National Reference Laboratory for TB and microbiology tests. 
This will enable IPCI to better and further sustain the efforts in 27 
Anti-Tuberculosis Centers (CATs) and in 16 regional reference 
laboratories previously supported for decentralized microbiology 
diagnosis.
    IPCI is in a unique position to conduct this work as it is the 
designated laboratory institution in charge of integrated Disease 
Surveillance and Response (IDSR) in Cote d'Ivoire by the Ministry of 
Health (MOH) and Ministry of Scientific Research. IPCI is responsible 
for the implementation, monitoring, and evaluation of population-based 
TB, malaria and epidemic disease surveillance, including HIV 
opportunistic infections, as well as prevention and care policies and 
interventions.

Summary of the Award

    Recipient: IPCI.
    Purpose of the Award: The purpose of this award is to sustain 
decentralization of HIV-associated microbiology at regional hospitals 
and to expand interventions to additional regional hospitals. It will 
improve support to and the coordination of the TB and OIs laboratory 
network for quality assured diagnosis of TB/DR-TB, including smear 
microscopy (LED), Lipoarabinomannan Assay (LF-LAM) for the diagnosis 
and screening of active tuberculosis in people with HIV, solid and 
liquid culture, and molecular WHO-recommended diagnostic tests (LIPA, 
Xpert Ultra).
    Amount of Award: The approximate year 1 funding amount will be 
$1,000,000 in Federal Fiscal Year (FYY) 2022 funds, subject to the 
availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Authority: Public Law 108-25 (the United States Leadership Against 
HIV AIDS, Tuberculosis and Malaria Act of 2003).
    Period of Performance: September 30, 2022 through September 29, 
2027.

    Dated: March 2, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-04790 Filed 3-7-22; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.